Reuters logo
BRIEF-Adverum says Regeneron Pharma elects to extend research term of deal
March 1, 2017 / 10:01 PM / 9 months ago

BRIEF-Adverum says Regeneron Pharma elects to extend research term of deal

March 1 (Reuters) - Adverum Biotechnologies Inc:

* Adverum Biotechnologies-on Feb 23, Regeneron Pharma notified Adverum Biotechnologies of election to extend research term of collaboration, licensing deal

* Adverum Biotechnologies - Regeneron Pharma elected to extend research term of deal for additional three years, through May 1, 2020 Source text: (bit.ly/2lV2kKY) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below